International Assets Investment Management LLC Raises Position in Privia Health Group, Inc. (NASDAQ:PRVA)

International Assets Investment Management LLC grew its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 2,721.7% during the fourth quarter, Holdings Channel reports. The fund owned 7,139 shares of the company’s stock after purchasing an additional 6,886 shares during the period. International Assets Investment Management LLC’s holdings in Privia Health Group were worth $164,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in PRVA. Riverbridge Partners LLC boosted its position in shares of Privia Health Group by 8.7% during the fourth quarter. Riverbridge Partners LLC now owns 4,342,385 shares of the company’s stock valued at $100,005,000 after purchasing an additional 348,852 shares in the last quarter. Trust Point Inc. bought a new stake in shares of Privia Health Group during the 4th quarter valued at $585,000. Bell Bank grew its position in shares of Privia Health Group by 49.1% in the 4th quarter. Bell Bank now owns 27,758 shares of the company’s stock worth $639,000 after buying an additional 9,143 shares during the period. Renaissance Capital LLC increased its stake in shares of Privia Health Group by 28.8% in the 4th quarter. Renaissance Capital LLC now owns 71,299 shares of the company’s stock worth $1,642,000 after acquiring an additional 15,943 shares in the last quarter. Finally, Baron Wealth Management LLC purchased a new position in Privia Health Group during the 4th quarter valued at about $237,000. Institutional investors own 94.48% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the stock. Barclays assumed coverage on shares of Privia Health Group in a report on Wednesday, March 6th. They issued an “equal weight” rating and a $22.00 price objective on the stock. Jefferies Financial Group started coverage on Privia Health Group in a research report on Monday, February 26th. They set a “buy” rating and a $25.00 price objective for the company. TD Cowen dropped their target price on Privia Health Group from $30.00 to $26.00 and set an “outperform” rating on the stock in a report on Friday, March 1st. Canaccord Genuity Group reduced their price target on Privia Health Group from $41.00 to $37.00 and set a “buy” rating for the company in a report on Tuesday, March 19th. Finally, Evercore ISI dropped their price target on shares of Privia Health Group from $26.00 to $25.00 and set an “outperform” rating on the stock in a research note on Wednesday, February 28th. Two equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $27.92.

Insider Buying and Selling

In other Privia Health Group news, CFO David Mountcastle sold 3,933 shares of the stock in a transaction dated Tuesday, April 2nd. The stock was sold at an average price of $17.77, for a total value of $69,889.41. Following the transaction, the chief financial officer now owns 262,279 shares of the company’s stock, valued at $4,660,697.83. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 14.20% of the stock is currently owned by corporate insiders.

Privia Health Group Stock Performance

PRVA opened at $18.26 on Monday. The company’s 50-day simple moving average is $19.81 and its two-hundred day simple moving average is $21.22. Privia Health Group, Inc. has a 52-week low of $17.54 and a 52-week high of $30.15. The stock has a market capitalization of $2.17 billion, a P/E ratio of 96.11, a P/E/G ratio of 2.50 and a beta of 0.81.

Privia Health Group (NASDAQ:PRVA) last issued its earnings results on Tuesday, February 27th. The company reported $0.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by ($0.02). The company had revenue of $440.80 million during the quarter, compared to analysts’ expectations of $425.81 million. Privia Health Group had a return on equity of 3.97% and a net margin of 1.39%. The company’s revenue for the quarter was up 21.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.14 EPS. Research analysts forecast that Privia Health Group, Inc. will post 0.26 EPS for the current fiscal year.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.